[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584236":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":38,"responsibleParty":55,"collaborators":26,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":26,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":26,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":80,"whyStopped":26,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Wecare Probiotics Co., Ltd.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Probiotic group","ACTIVE_COMPARATOR","Intervention with Bifidobacterium bifidum BBi32 (30 billion CFUday, 3g) was administered daily for 8 weeks.",[13],"Dietary Supplement: Probiotic",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo group","PLACEBO_COMPARATOR","Every day to give 3 g maltodextrin intervention for 8 weeks.",[19],"Dietary Supplement: Placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIETARY_SUPPLEMENT","Probiotic","Dietary supplement: Probiotics. The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Placebo","Dietary supplement: Placebo. The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},"Xu Fei Doctor","CONTACT","13671979116","86","xu.fei@haut.edu.cn",[39],{"facility":40,"status":26,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Henan University of Technology","Zhengzhou","Henan","210095","China","CN",{"type":47,"coordinates":48},"Point",[49,50],113.64861,34.75778,{"lat":50,"lon":49},[53],{"name":54,"role":34,"phone":35,"phoneExt":36,"email":37},"Xu fei Doctor",{"type":56,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100584236","research-on-the-role-of-probiotics-in-human-intestinal-health-100584236",false,"NCT06886711","Research on the Role of Probiotics in Human Intestinal Health","A Study on the Safety and Efectiveness of Bifidobacterium Bifidum BBi32 in Improving Lntestinal and Lmmune Functions","Inclusion Criteria:\n\n1. Willing to attend 3 follow-up visits during the intervention period\n2. Agree to provide blood, urine, and stool samples twice during the intervention period\n3. Good eyesight, able to read and write, and capable of wearing glasses if needed\n4. Good hearing and able to fully comprehend all instructions during the intervention\n\nExclusion Criteria:\n\n1. Presence of digestive diseases, particularly gastrointestinal disorders (e.g., celiac disease, ulcerative colitis, Crohn's disease)\n2. History of serious neurological conditions (e.g., epilepsy, stroke, severe head trauma, meningitis within the last 10 years, brain surgery, brain tumor, or prolonged coma-not including general anesthesia)\n3. History of or currently receiving treatment for mental health disorders such as alcohol\u002Fdrug\u002Fsubstance abuse, schizophrenia, psychosis, or bipolar disorder\n4. Currently taking medication for depression or low mood\n5. Presence of internal organ failure (e.g., heart, liver, or kidney failure)\n6. History of radiation therapy or chemotherapy treatments\n7. Underwent general anesthesia within the past three years or are scheduled for general anesthesia within the next 3 months during the trial period\n8. History of hepatitis (B or C), HIV, or syphilis",true,"ALL","18 Years","45 Years",{"count":69,"type":70},45,"ESTIMATED","INTERVENTIONAL",[73],"NA","Evaluate the efectiveness and safety of Bifidobacterium bifidum BBi32 as a food supplement compared to a placebo in improving intestinal andimmune functions in healthy adults.",[76],"Intestinal Microbiota",[78,79],"Probiotics","Intestinal Barrier Function","NOT_YET_RECRUITING","2025-03-13",{"date":83,"type":84},"2025-03-20","ACTUAL",{"date":86,"type":70},"2025-03-10",{"date":88,"type":70},"2025-12-30",{"name":5,"class":6},1]